• Modeling Pseudomonas aeruginosa Resistance via ampC/ampD Mut

  2026-04-20

  This study dissects how specific ampC and ampD mutations drive both acquired and adaptive resistance to ceftolozane-tazobactam in Pseudomonas aeruginosa. By integrating whole genome sequencing with semi-mechanistic PKPD modeling, the authors quantify the impact of each mutation and their combinations on antimicrobial susceptibility profiles, offering a nuanced framework for resistance mechanism analysis.

• Digoxin as a Na+/K+ ATPase Pump Inhibitor: Workflow & Troubl

  2026-04-20

  Digoxin, a high-purity Na+/K+ ATPase pump inhibitor, powers both cardiovascular and antiviral research with reproducible, cell-type-specific effects. This guide breaks down applied protocols, cross-domain innovations, and actionable troubleshooting to maximize data quality and translational insights.

• GW4064: Mechanistic Leverage for Translational FXR Research

  2026-04-19

  Explore how GW4064, a potent non-steroidal FXR agonist, is redefining metabolic, fibrotic, and ferroptosis research. This thought-leadership article integrates mechanistic insight, translational strategy, and new evidence—highlighting GW4064’s role in dissecting the FXR/TLR4 pathway and collagen regulation. Gain actionable guidance, protocol best practices, and a strategic outlook for translational researchers.

• LMP7 in Airway Epithelium: Key to Influenza Defense and Infl

  2026-04-18

  This study reveals that the immunoproteasome subunit LMP7 in airway epithelial cells is essential for controlling inflammation and limiting rhinovirus (RV) infection. Conditional LMP7 knockout models demonstrated that LMP7 deficiency increases viral burden and cytokine production, highlighting a protective, anti-inflammatory role with implications for developing targeted therapies.

• Agatoxin-IVA-Sensitive Calcium Channels in Cardiac Vagal Neu

  2026-04-17

  This study identifies P/Q-type (agatoxin-IVA-sensitive) calcium channels as essential mediators of both presynaptic and postsynaptic nicotinic activation in cardiac vagal neurons. These findings clarify the mechanistic basis of cholinergic control of heart rate and provide a targeted framework for electrophysiological investigation of synaptic transmission in the brainstem.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Resp

  2026-04-16

  This study introduces a patient-specific gastric cancer assembloid model integrating tumor organoids with matched stromal cell subpopulations. The model more accurately recapitulates tumor heterogeneity and microenvironment, enabling improved drug response profiling and resistance studies.

• Biotin-XX Tyramide Reagent: Enabling Quantitative Cell Surfa

  2026-04-15

  Explore how Biotin-XX Tyramide Reagent advances quantitative, membrane-impermeant cell surface mapping in neural and cellular research. Discover unique technical insights and protocol strategies for tyramide signal amplification beyond standard IHC and ISH applications.

• Wnt and BMP Pathways Pattern Neuroectoderm in Hemichordates

  2026-04-14

  This study demonstrates that dynamically regulated Wnt and BMP signaling gradients pattern the anterior neuroectoderm (ANE) in the indirect-developing hemichordate Ptychodera flava. The findings reveal evolutionarily conserved and biphasic roles for these pathways in early deuterostome development, providing a valuable comparative framework for Wnt pathway research.

• SEMA3E Drives Beige Adipocyte Thermogenesis via β-Catenin in

  2026-04-13

  This study reveals that SEMA3E, a class 3 semaphorin, is a key regulator of beige adipocyte differentiation and thermogenic activity through modulation of the Wnt/β-catenin pathway in mice. These findings provide new mechanistic insights into adipose tissue plasticity and metabolic regulation, with implications for metabolic disorder research.

• Flubendazole in Translational Autophagy: Beyond Assays

  2026-04-12

  This thought-leadership article provides mechanistic and strategic guidance for translational researchers leveraging Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) as a precision autophagy activator. Integrating in vitro assay advances, comparative reagent analysis, and translational strategy, we illuminate how Flubendazole enables next-generation autophagy modulation research in cancer and neurodegenerative disease models. Building on recent literature and in-depth product intelligence, this article navigates best practices, pitfalls, and visionary outlooks for the translational autophagy field.

• Nanoparticle-Mediated mRNA Delivery Reverses Trastuzumab Res

  2026-04-12

  This study introduces a nanoparticle-based platform for systemic delivery of PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN and inhibiting PI3K/Akt signaling, the approach demonstrates effective tumor suppression and provides a blueprint for advanced mRNA therapeutics.

• Cy5-UTP: Precision RNA Labeling for Advanced FISH & Probes

  2026-04-11

  Cy5-UTP (Cyanine 5-uridine triphosphate) delivers high-sensitivity, direct fluorescent RNA labeling for cutting-edge applications like FISH and dual-color arrays. Its robust incorporation streamlines probe synthesis, enables real-time visualization, and empowers troubleshooting in even the most challenging workflows.

• MK-2206 dihydrochloride: Applied Workflows in Akt Pathway Re

  2026-04-11

  MK-2206 dihydrochloride empowers researchers with precise Akt pathway inhibition, facilitating robust apoptosis and cancer studies. This guide details real-world protocol design, troubleshooting, and workflow enhancements, translating new mechanistic insights into practical lab solutions.

• PF-562271 HCl: Unveiling FAK/Pyk2 Inhibition in Tumor Nic...

  2026-04-10

  Explore the unique role of PF-562271 HCl as a selective FAK/Pyk2 inhibitor in dissecting the early metastatic niche and tumor microenvironment modulation. This cornerstone article delves into advanced mechanisms and research models, offering new insights for cancer research.

• Cefotaxime (SKU BA1012): Best Practices for Reliable Anti...

  2026-04-09

  This article addresses real-world laboratory challenges in antimicrobial resistance research, focusing on how Cefotaxime (SKU BA1012) ensures reproducibility and sensitivity in bacterial infection models. Drawing on validated protocols and current literature, we provide scenario-driven guidance for experimental design, data interpretation, and vendor selection, positioning APExBIO’s Cefotaxime as a robust solution for rigorous bench scientists.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page